These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11509741)

  • 1. Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicol Sci; 2001 Sep; 63(1):29-36. PubMed ID: 11509741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selenite on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2003 Apr; 186(1-2):33-50. PubMed ID: 12604169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats.
    Gregus Z; Gyurasics A; Csanaky I
    Toxicol Sci; 2000 Jul; 56(1):18-25. PubMed ID: 10869450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites.
    Csanaky I; Gregus Z
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):355-65. PubMed ID: 11912060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent biotransformation of arsenite in rats--not S-adenosylmethionine depletion impairs arsenic methylation at high dose.
    Csanaky I; Németi B; Gregus Z
    Toxicology; 2003 Feb; 183(1-3):77-91. PubMed ID: 12504344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an inactivator of glyceraldehyde-3-phosphate dehydrogenase, a fortuitous arsenate reductase, on disposition of arsenate in rats.
    Németi B; Csanaky I; Gregus Z
    Toxicol Sci; 2006 Mar; 90(1):49-60. PubMed ID: 16322075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria work as reactors in reducing arsenate to arsenite.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2002 Aug; 182(3):208-18. PubMed ID: 12183100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenate reduction in human erythrocytes and rats--testing the role of purine nucleoside phosphorylase.
    Nemeti B; Csanaky I; Gregus Z
    Toxicol Sci; 2003 Jul; 74(1):22-31. PubMed ID: 12730608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ability in AsIII oxidation and AsV reduction: Relation to arsenic tolerance, P uptake, and siderophore production.
    Ghosh P; Rathinasabapathi B; Teplitski M; Ma LQ
    Chemosphere; 2015 Nov; 138():995-1000. PubMed ID: 25576133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP.
    Németi B; Regonesi ME; Tortora P; Gregus Z
    Toxicol Sci; 2010 Oct; 117(2):270-81. PubMed ID: 20457661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo reduction of arsenate in mice and rabbits.
    Vahter M; Envall J
    Environ Res; 1983 Oct; 32(1):14-24. PubMed ID: 6617606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
    Németi B; Gregus Z
    Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High As exposure induced substantial arsenite efflux in As-hyperaccumulator Pteris vittata.
    Chen Y; Fu JW; Han YH; Rathinasabapathi B; Ma LQ
    Chemosphere; 2016 Feb; 144():2189-94. PubMed ID: 26595313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):154-61. PubMed ID: 19248796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol - characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2005 Jun; 85(2):847-58. PubMed ID: 15788720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
    Gregus Z; Roos G; Geerlings P; Németi B
    Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotoxicity of arsenate and arsenite on juvenile mice at organism, subcellular, and gene levels under low exposure.
    Sun HJ; Li SW; Li C; Wang WQ; Li HB; Ma LQ
    Chemosphere; 2017 Nov; 186():580-587. PubMed ID: 28813693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of arsenate to arsenite in hepatic cytosol.
    Németi B; Gregus Z
    Toxicol Sci; 2002 Nov; 70(1):4-12. PubMed ID: 12388829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic uptake, arsenite efflux and plant growth in hyperaccumulator Pteris vittata: Role of arsenic-resistant bacteria.
    Han YH; Fu JW; Chen Y; Rathinasabapathi B; Ma LQ
    Chemosphere; 2016 Feb; 144():1937-42. PubMed ID: 26547029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.